With regard to depressive disorders, hyperactivation of the cholinergic pathway by nicotinic acetylcholine receptor (nAChR) agonists or acetylcholinesterase inhibitors brings forward depression in patients, even in adolescents [5,6,7,8]. Here, CHRNA4 is linked to depressive disorder.